Valuation Surveys in Other Countries

There is emerging evidence that SG health state values differ between countries for SG. There have been valuation surveys completed in Japan, Hong Kong, Portugal and Brazil using similar methods to those used in UK. Details on these surveys can be found in the publications listed at the bottom of this note. Surveys have also been undertaken in Australia, Spain and Singapore, but the results have yet to be published.

Researchers interested in using the SF-6D in these countries should contact the names listed below:-

Australia

Rosalie Viney: rosalie.viney@chere.uts.edu.au
Madeline King: madeleine.king@chere.uts.edu.au

Brazil

Luciane Cruz:lncruz@ig.com.br
Marcelo Fleck: mfleck.voy@zaz.com.br

Hong Kong

Cindy Lam: clklam@hku.hk
Sarah McGhee: smmcghee@hkucc.hku.hk

Japan

Shunichi Fukuhara: fukuhara@pbh.med.kyoto-u.ac.jp

Portugal

Lara Nobre Noronha Ferreira: lnferrei@ualg.pt
Pedro Lopes Ferreira: pedrof@fe.uc.pt

Singapore

Nan Luo: medln@nus.edu.sg

Spain

José María Abellán: dionisos@um.es

Publications on valuation surveys conducted in other countries

Lam CLK, Brazier J, McGhee SM. Valuation of the SF-6D health states is feasible, acceptable, reliable and valid in a Chinese population. Value in Health 2008;11:295-303.

Brazier JE, Fukuhara S, Roberts J, Kharoubi S et al. Estimating a preference-based index from the Japanese SF-36. Journal of Clinical Epidemiology; 62(12): 1323-1331.

Ferreira LN, Ferreira PL, Brazier J, Rowen D. A Portugese value set for the SF-6D. Value in Health 2010; 13(5): 624-630.